Eris Lifesciences Limited (BOM:540596)

India flag India · Delayed Price · Currency is INR
1,417.70
+33.70 (2.43%)
At close: Jan 22, 2026
12.13%
Market Cap196.52B
Revenue (ttm)29.86B
Net Income (ttm)4.15B
Shares Outn/a
EPS (ttm)30.46
PE Ratio47.35
Forward PE31.71
Dividend7.35 (0.53%)
Ex-Dividend DateFeb 13, 2025
Volume1,735
Average Volume4,471
Open1,356.95
Previous Close1,384.00
Day's Range1,356.95 - 1,432.00
52-Week Range1,130.05 - 1,909.55
Betan/a
RSI34.20
Earnings DateFeb 6, 2026

About Eris Lifesciences

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electro... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 3,354
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540596
Full Company Profile

Financial Performance

In 2024, Eris Lifesciences's revenue was 28.79 billion, an increase of 44.59% compared to the previous year's 19.91 billion. Earnings were 3.52 billion, a decrease of -10.26%.

Financial Statements